mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.2 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.067 |
0.2 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.2 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.068 |
0.2 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.2 |